EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 4basebio's enterprise value is €209.70 Mil.
4basebio's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.41 Mil. Therefore, 4basebio's EV-to-Revenue for today is 511.47.
The historical rank and industry rank for 4basebio's EV-to-Revenue or its related term are showing as below:
XTER:88Q'
s EV-to-Revenue Range Over the Past 10 Years
Min: 53.89 Med: 197.31 Max: 529.39
Current: 509.86
During the past 4 years, the highest EV-to-Revenue of 4basebio was 529.39. The lowest was 53.89. And the median was 197.31.
XTER:88Q's EV-to-Revenue is ranked worse than 92.2% of 1038
companies
in the Biotechnology industry
Industry Median: 7.97
vs XTER:88Q: 509.86
As of today (2024-05-15), 4basebio's stock price is €16.80.
4basebio's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.03. Therefore, 4basebio's PS Ratio for today is 509.09.
4basebio EV-to-Revenue Historical Data
The historical data trend for 4basebio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of 4basebio's EV-to-Revenue
For the Biotechnology subindustry, 4basebio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4basebio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 4basebio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where 4basebio's EV-to-Revenue falls into.
4basebio's current Enterprise Value is €209.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4basebio's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4basebio's share price for today is €16.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was €0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4basebio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of 4basebio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:88Q has been successfully added to your